# Neuphoria Therapeutics Inc.: Form 6-K, filed Dec 16, 2022

- Company: [Neuphoria Therapeutics Inc.](/companies/neup.md) (CIK 1191070)
- Form: 6-K
- Filed: 2022-12-16
- Accepted by EDGAR: Dec 16, 2022, 11:03 ET
- Period: 2022-12-16
- Accession: 0000950170-22-026631
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1191070/000095017022026631/bnox-6k-appoint_ceo.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1191070/000095017022026631/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1191070/000095017022026631/bnox-6k-appoint_ceo.htm

Filed Dec 16, 2022.
Source: SEC EDGAR, the filing index for accession 0000950170-22-026631. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.